MCA logo



Gadopiclenol (Elucirem™) for Contrast-Enhanced MRI

The US FDA granted regulatory approval to Gadopiclenol (Elucirem™), a new macrocyclic GBCA for use in adults and children aged 2 years and older, for contrast-enhanced MRI.

Sign Up or Log In as a healthcare professional to read the full article.

Share via

Also worth reading

People also read:

monkeypox thailand
Monkeypox Emerges in Thailand: First Death and 189 Cases Reported

The Songkhla Provincial Public Health Office confirmed the first monkeypox (mpox) case in the region. A 31-year-old Thai man from Songkhla was admitted to the hospital on Wednesday, and the diagnosis was made the following day. The hospital followed the prevention guidelines by isolating the patient. The health office initiated contact tracing, identifying one low-risk and one high-risk contact, while others were advised to self-monitor.

Read More »